These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 22652186)
1. [Efficacy and safety of botulinum toxin in the treatment of sialorrhea in children with neurological disorders]. García Ron A; Miranda MC; Garriga Braun C; Jensen Verón J; Torrens Martinez J; Diez Hanbino MP An Pediatr (Barc); 2012 Oct; 77(4):289-91. PubMed ID: 22652186 [No Abstract] [Full Text] [Related]
2. Botulinum toxin A for treatment of sialorrhea in children: an effective, minimally invasive approach. Khan WU; Campisi P; Nadarajah S; Shakur YA; Khan N; Semenuk D; McCann C; Roske L; McConney-Ellis S; Joseph M; Parra D; Amaral J; John P; Temple M; Connolly B Arch Otolaryngol Head Neck Surg; 2011 Apr; 137(4):339-44. PubMed ID: 21242533 [TBL] [Abstract][Full Text] [Related]
3. Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy? Vaile L; Finlay F Arch Dis Child; 2006 Oct; 91(10):862-3. PubMed ID: 16990361 [No Abstract] [Full Text] [Related]
4. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B. Wilken B; Aslami B; Backes H Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707 [TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy? Santamato A; Panza F; Solfrizzi V; Frisardi V; Ranieri M; Fiore P J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630 [No Abstract] [Full Text] [Related]
6. Botulinum toxin type A and B for the reduction of hypersalivation in children with neurological disorders: a focus on effectiveness and therapy adherence. Schroeder AS; Kling T; Huss K; Borggraefe I; Koerte IK; Blaschek A; Jahn K; Heinen F; Berweck S Neuropediatrics; 2012 Feb; 43(1):27-36. PubMed ID: 22430158 [TBL] [Abstract][Full Text] [Related]
7. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms. Møller E; Karlsborg M; Bardow A; Lykkeaa J; Nissen FH; Bakke M Acta Odontol Scand; 2011 May; 69(3):151-7. PubMed ID: 21198339 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience. Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402 [TBL] [Abstract][Full Text] [Related]
10. Incobotulinumtoxin A for Sialorrhea in Neurological Disorders: A Real-Life Experience. Martínez-Poles J; Nedkova-Hristova V; Escribano-Paredes JB; García-Madrona S; Natera-Villalba E; Estévez-Fraga C; López-Sendón Moreno JL; Avilés-Olmos I; Sánchez Díaz G; Martínez Castrillo JC; Alonso-Canovas A Toxins (Basel); 2018 May; 10(6):. PubMed ID: 29843420 [TBL] [Abstract][Full Text] [Related]
11. Salivary botulinum toxin injection may reduce aspiration pneumonia in neurologically impaired children. Faria J; Harb J; Hilton A; Yacobucci D; Pizzuto M Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2124-8. PubMed ID: 26478107 [TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin for the treatment of sialorrhea: a meta-analysis. Vashishta R; Nguyen SA; White DR; Gillespie MB Otolaryngol Head Neck Surg; 2013 Feb; 148(2):191-6. PubMed ID: 23112272 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of drooling with botulinum toxin type A in cerebral palsy]. Duarte CS; Alves TR; Azeredo PM; Almeida SI Rev Neurol; 2009 Dec 1-15; 49(11):610. PubMed ID: 19921629 [No Abstract] [Full Text] [Related]
14. Long-term safety and efficacy data on botulinum toxin type A: an injection for sialorrhea. Chan KH; Liang C; Wilson P; Higgins D; Allen GC JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):134-8. PubMed ID: 23429943 [TBL] [Abstract][Full Text] [Related]
15. Volume matters: the influence of different botulinum toxin-A dilutions for sialorrhea in amyotrophic lateral sclerosis. Anagnostou E; Rentzos M; Alexakis T; Zouvelou V; Zambelis T; Evdokimidis I Muscle Nerve; 2013 Feb; 47(2):276-8. PubMed ID: 23281147 [TBL] [Abstract][Full Text] [Related]
16. Botulinum Toxin in the Management of Sialorrhoea in Acquired Brain Injury. Carrol A; McGlone B Ir Med J; 2016 Jun; 109(6):425. PubMed ID: 27814442 [TBL] [Abstract][Full Text] [Related]
17. Applied botulinum neurotoxin injection in a patient with dementia to reduce hypersalivation. Yuruyen M; Gokturk A; Yavuzer H; Döventas A; Erdincler DS Geriatr Gerontol Int; 2017 Jun; 17(6):1028-1029. PubMed ID: 28635110 [No Abstract] [Full Text] [Related]
18. Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease. Melo A; Rodrigues B; Nóbrega AC J Am Geriatr Soc; 2009 Jan; 57(1):180; author reply 180-1. PubMed ID: 19170803 [No Abstract] [Full Text] [Related]
19. Efficacy and duration of botulinum toxin treatment for drooling in 131 children. Scheffer AR; Erasmus C; van Hulst K; van Limbeek J; Jongerius PH; van den Hoogen FJ Arch Otolaryngol Head Neck Surg; 2010 Sep; 136(9):873-7. PubMed ID: 20855679 [TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin for treatment of parkinsonian sialorrhea. Friedman A; Potulska A Neurol Neurochir Pol; 2001; 35 Suppl 3():23-7. PubMed ID: 12001650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]